Age: 21-70
Condition: Overweight patients with a BMI of 30-45 who will be provided tirzepatide to lose 15% of your body weight. To follow, an upper GI endoscopy with a groundbreaking procedure called a DMR to see if it will help maintain your weight loss. (Can not be Diabetic)
Study length: 52 weeks, 24 visits. 14 in office visits and 10 phone call visits.
Provided: AT NO COST-Study medication-tirzepatide, study procedure, tests and exams with compensation for time and travel.